Subscribe to Search results

Within the minutes of a UK Haemophilia Centre directors meeting it was described by Dr Mayne as limited quantities of concentrate from Elstree and Oxford.

Published on:

Within his written statement to the Inquiry Dr Morris McClelland advised that there were capacity issues at BPL.

Published on:

Table showing annual consumption of Commercial Factor Concentrates.

Published on:

In oral evidence to the Inquiry, Dr Terence Snape apologised for not doing more, sooner.

Published on:

A statement from an investigative reporter investigating Belize's trade in plasma to the US described how a visitor to his motel room told him to take the first plane out the following morning. He left the next day.

Published on:

Cohn fractionation offered a way of separating blood into its constituent parts, and opened the possibility of using that part which was responsible for helping blood to clot without the far greater volume of blood from which it was separated.

Published on:

A lack of close oversight by the DHSS contributed to delays and expense in the redevelopment of BPL.

Published on:

Dr Maycock probably told the Chief Medical Officer that production facilities were not designed for the task nor large enough.

Published on:

A forward-looking interest was taken to updating and renewing production facilities.

Published on:

Additional major investment was needed in the UK if self-sufficiency was to be achieved.

Published on:

Inflation had exceeded 20% in 1975; and GDP had declined in both 1973 and 1975. Unemployment had peaked in 1976 at 1.5 million.

Published on:

Public expenditure increased in 1978-79.

Published on:

Oxford was known to provide a greater quantity of clotting factors than most if not all of the other centres at the time.

Published on:

Figure for the annual consumption of Factor 8 in the UK 23 August 1999.

Published on:

Figure showing annual consumption of CFC 1976 to 1994.

Published on:

Dr Walford understood from her visit to PFC that Liberton had a substantial capacity for expansion notwithstanding substantial staffing difficulties.

Published on:

For years, it was considered that because domestic blood products were manufactured by agents of the Crown, Crown immunity rendered domestic products free of similar controls.

Published on:

Mr Wormald favoured the expansion of PFC as well as rebuilding Elstree.

Published on:

A paper by the Economic Advisors' Office concluded that the most economic option available to meet the NBS' demand for blood products was to redevelop BPL.

Published on:

A briefing paper on Blood Products Laboratory Redevelopment said that "Given that the present BPL has to be redeveloped ... it would be more expensive to build a smaller BPL (£18.6 million) and invest £4 million in PFC than to build a BPL capable of achieving self-sufficiency (£21.03 million)."

Published on: